COVID-19
-
Study sheds light on diabetes and COVID interaction
COVID-19 has been linked to cases of new-onset diabetes, diabetes-related emergencies and a higher death rate among diabetes patients. Read MoreDec 10, 2020
-
Vanderbilt University Medical Center’s Crowe receives 2020 “Golden Goose” Award for COVID-19 research
James Crowe Jr., MD, a physician-scientist at Vanderbilt University Medical Center who has pioneered development of human monoclonal antibodies as potential treatments for viral diseases, has won a 2020 “Golden Goose” Award. Read MoreDec 1, 2020
-
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Read MoreNov 18, 2020
-
Engineering lab returns during Vanderbilt’s Research Ramp-up to advance research in neurodegeneration
The lab of Ethan Lippmann, assistant professor of chemical and biomolecular engineering and biomedical engineering, seeks to model, understand, and ultimately treat neurodegeneration, focusing primarily on the blood-brain barrier, a border of protective blood vessels found in the brain. Before the COVID-19 pandemic, Lippmann’s team in the Neurovascular Engineering and Therapeutic Design Laboratory was firing... Read MoreNov 16, 2020
-
Younger parents less likely to vaccinate their children and themselves against COVID-19
Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19. Read MoreNov 16, 2020
-
Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read MoreNov 9, 2020
-
VUMC begins study of second COVID-19 vaccine
Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read MoreNov 2, 2020
-
Lunch Date: Students find new ways to connect amid COVID-19 safety protocols
As students returned to campus amid numerous COVID-19 safety protocols, they found new ways to connect. Here, students enjoy a physically distant lunch together in front of the newly opened Nicholas S. Zeppos College. Read MoreOct 29, 2020
-
Creating Our Proudest Moment: Vanderbilt’s spirit of collaboration and compassion shines through amid historic circumstances
As we continue to navigate a fall semester like no other, and as I embark on my first academic year as Vanderbilt’s chancellor, I am increasingly impressed by the strength of our university community. Read MoreOct 26, 2020
-
Possible COVID-19 “decoy”
It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection. Read MoreOct 15, 2020
-
COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials
AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. Read MoreOct 13, 2020
-
How to spot misinformation—and what to do about it: Expert advice from psychology professor Lisa Fazio
Lisa Fazio, assistant professor of psychology and human development at Peabody College, shares a few tips on how to avoid knowledge neglect and spreading misinformation. Read MoreSep 22, 2020
-
Rational vaccine design
Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development. Read MoreSep 22, 2020
-
Possible key to COVID-19 infectivity
New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment. Read MoreSep 7, 2020
-
Study to track if COVID can spread during minimally invasive surgery
Physician-scientists at Vanderbilt University Medical Center are investigating whether SARS-CoV-2, the virus that causes COVID-19, can be spread through aerosolized emissions (microscopic droplets and particles) during minimally invasive surgery in children. Read MoreAug 27, 2020
-
VUMC awarded $34 million to lead nationwide convalescent plasma study
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19. Read MoreAug 21, 2020
-
Get to know Vanderbilt’s residential faculty: Professor Celso Castilho
As the new academic year approaches, Vanderbilt's faculty heads of house are revealing some things about themselves in this special portrait series. Meet Celso Thomas Castilho, associate professor of history and faculty head of Memorial House. Read MoreAug 1, 2020
-
Soaring Salute: Blue Angels’ Nashville flyover honors health care workers, first responders
The U.S. Navy’s Blue Angels flight demonstration squadron soar directly above Vanderbilt Stadium on May 14 during a series of nationwide flyovers, which included Nashville. Read MoreJul 29, 2020
-
Get to know Vanderbilt’s residential faculty: Professor Christoph Zeller
As the new academic year approaches, Vanderbilt’s faculty heads of house are revealing some things about themselves in this special portrait series. Get to know Christoph Zeller, associate professor of German studies and of European studies and faculty head of West House. Read MoreJul 29, 2020
-
Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19
Based on positive results in preclinical studies reported today, potently neutralizing antibodies identified by researchers at Vanderbilt University Medical Center are showing promise as a potential therapy for preventing and treating COVID-19. Read MoreJul 15, 2020